Dramatic Regression of Chronic Lymphocytic Leukemia in the First Patient Treated With Donor-Derived Genetically-Engineered Anti-CD19-Chimeric-Antigen-Receptor-Expressing T Cells After Allogeneic Hematopoietic Stem Cell Transplantation

✍ Scribed by J.N. Kochenderfer; M.E. Dudley; I. Maric; S.A. Feldman; R. Salit; N.M. Hardy; P. Layton; B. Blacklock-Schuver; J. Wilder; L. Devillier; R.E. Gress; R.A. Morgan; S.A. Rosenberg; M.R. Bishop

• Book ID: 116281995
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 60 KB
• Volume: 17
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2010.12.025